Journal article
Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN
R Torra, B Lipska-Zietkiewicz, F Acke, C Antignac, JU Becker, E Cornec-Le Gall, AM Van Eerde, N Feltgen, R Ferrari, DP Gale, S Gear, O Gross, S Haeberle, L Heidet, R Lennon, L Massella, K Pfau, MDPV Pizarro, R Topaloglu, T Wlodkowski Show all
Nephrology Dialysis Transplantation | Published : 2025
DOI: 10.1093/ndt/gfae265
Open access
Abstract
Glomerular nephropathy resulting from the genetic defects in COL4A3/4/5 genes including the classical Alport syndrome is the second most common hereditary kidney disease characterized by persistent haematuria progressing to the need for kidney replacement therapy, frequently associated with sensorineural deafness, and occasionally with ocular anomalies. Diagnosis and management of COL4A3/4/5 glomerulopathy is a great challenge due to its phenotypic heterogeneity, multiple modes of inheritance, variable expressivity, and disease penetrance of individual variants as well as imperfect prognostic and progression factors and scarce and limited clinical trials, especially in children. As a joint i..
View full abstractGrants
Awarded by European Rare Kidney Disease Reference Network